Clinical Trial Update: Trial Investigating the Safety of NNC 0113-0987 in Healthy Male Subjects [Phase 1]

View source ↗

Summary

A Phase 1 safety trial of the investigational diabetes drug NNC 0113-0987 in healthy male volunteers has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• NNC 0113-0987

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Phase 1 | Status: COMPLETED